[1] Cunha and R. A. O. Calsolari, “Toxigenicity in Staphylococcus aureus and coagulase-negative staphylococci: epidemiological and molecular aspects,” Microbiol. Insights, vol. 1, p. MBI--S796, 2008. 

[2] T. M. de Moura et al., “Prevalence of enterotoxin-encoding genes and antimicrobial resistance in coagulase-negative and coagulase-positive Staphylococcus isolates from black pudding,” Rev. Soc. Bras. Med. Trop., vol. 45, no. 5, pp. 579–585, 2012. 

[3] J. R. Lentino, M. Narita, and V. L. Yu, “New antimicrobial agents as therapy for resistant gram-positive cocci,” Eur. J. Clin. Microbiol. Infect. Dis., vol. 27, no. 1, pp. 3–15, 2008, doi: 10.1007/s10096-007- 0389-y. 

[4] D. C. Shore, Anna C and Coleman, “Staphylococcal Cassette Chromosome mec: Recent Advances and New Insights,” Int. J. Med. Microbiol., vol. 303, pp. 350–359, 2013. 

[5] M. S. Aski, "Characterization of hemolysins of Staphylococcus strains isolated from human and bovine, southern Iran," ranian J. Vet. Res., vol. 15, no. 4, p. 326, 2014, doi: 10.22099/ijvr.2014.2586. 

[6] D. Oliveira, A. Borges, and M. Simões, “Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases,” toxin, vol. 10, no. 6, p. 25, 2018, doi: 10.3390/toxins10060252. 

[7] L. Pinheiro, C. I. Brito, A. de Oliveira, P. Y. F. Martins, V. C. Pereira, and M. de L. R. de S. da Cunha, "Staphylococcus epidermidis and Staphylococcus haemolyticus: Molecular detection of cytotoxin and enterotoxin genes," Toxins (Basel)., vol. 7, no. 9, pp. 3688–3699, 2015, doi: 10.3390/toxins7093688. 

[8] K. Burnside et al., “Regulation of Hemolysin Expression and Virulence of Staphylococcus aureus by a Serine / Threonine Kinase and Phosphatase,” PLoS One, vol. 5, no. 6, 2010, doi: 10.1371/journal.pone.0011071. 

[9] C. Marconi, M. Cunha, J. P. Araújo Jr, and L. Rugolo, “Standardization of the PCR technique for the detection of delta toxin in Staphylococcus spp.,” J. Venom. Anim. Toxins Incl. Trop. Dis., vol. 11, no. 2, pp. 117–128, 2005. 

[10] M. M. Dinges, P. M. Orwin, and P. M. Schlievert, “Exotoxins of Staphylococcus aureus,” Clin. Microbiol. Rev., vol. 13, no. 1, pp. 16–34, 2000. 

[11] L. B. Shrestha, N. R. Bhattarai, and B. Khanal, “Antibiotic resistance and biofilm formation among coagulase-negative staphylococci isolated from clinical samples at a tertiary care hospital of eastern Nepal,” Antimicrob. Resist. Infect. Control, vol. 6, no. 1, pp. 1–7, 2017, doi: 10.1186/s13756-017-0251- 7. 

[12] B. Kot, H. Sytykiewicz, and I. Sprawka, “Expression of the biofilm-associated genes in methicillin.resistant Staphylococcus aureus in biofilm and planktonic conditions,” Int. J. Mol. Sci., vol. 19, no. 11, 2018, doi: 10.3390/ijms19113487. 

[13] K. Becker, C. Heilmann, and G. Peters, “Coagulase-negative staphylococci,” Clin. Microbiol. Rev., vol. 27, no. 4, pp. 870–926, 2014, doi: 10.1128/CMR.00109-13. 

[14] T. Maira-Litrán et al., “Immunochemical Properties of the Staphylococcal,” vol. 70, no. 8, pp. 4433– 4440, 2002, doi: 10.1128/IAI.70.8.4433. 

[15] A. Piette and G. Verschraegen, “Role of coagulase-negative staphylococci in human disease,” Vet. Microbiol., vol. 134, no. 1–2, pp. 45–54, 2009, doi: 10.1016/j.vetmic.2008.09.009. 

[16] E. Knecht and F. Go, “Bap-dependent biofilm formation by pathogenic species of Staphylococcus : evidence of horizontal gene transfer ?,” Microbiology, vol. 151, no. 7, pp. 2465–2475, 2005, doi: 10.1099/mic.0.27865-0. 

[17] P. Herman-bausier, S. El-kirat-chatel, T. J. Foster, J. A. Geoghegan, and F. Dufrêne, "Staphylococcus aureus Fibronectin-Binding Protein A Mediates Cell-Cell Adhesion through Low-Affinity Homophilic Bonds," MBio, vol. 6, no. 3, pp. 1–10, 2015, doi: 10.1128/mBio.00413-15.Invited. 

[18] W. E. Kloos and K. H. Schleifer, "Simplified Scheme for Routine Identification of Human Staphylococcus Species g," J. Clin. Microbiol., vol. 1, no. 1, pp. 82–88, 1975. JZS-A Volume 24, Issue 1, June 2022 25 

[19] R. Buxton, “Blood Agar Plates and Hemolysis Protocols,” Am. Soc. Microbiol., no. May 2019, pp. 1– 9, 2005. 

[20] A. Ferrari and A. Signoroni, “Automatic hemolysis identification on aligned dual-lighting images of cultured blood agar plates,” Comput. Methods Programs Biomed., 2017. 

[21] T. Mathur, S. Singhal, S. Khan, D. J. Upadhyay, T. Fatma, and A. Rattan, “Detection of biofilm formation among the clinical isolates of staphylococci: An evaluation of three different screening methods,” Indian J. Med. Microbiol., vol. 24, no. 1, pp. 25–29, 2006, doi: 10.4103/0255-0857.19890. 

[22] P. S. Panda, U. ChaudharPanda, Pragyan Swagatika, Uma Chaudhary, Surya K Dube, and others. 2016. “Comparison of Four Different Methods for Detection of Biofilm Formation by Uropathogens.” Indian Journal of Pathology and Microbiology 59 (2): 177.y, S. K. Dube, and others, “Comparison of four different methods for detection of biofilm formation by uropathogens,” Indian J. Pathol. Microbiol., vol. 59, no. 2, p. 177, 2016. 

[23] H. M. Hamzah, R. F. Salah, and M. N. Maroof, “Fusarium mangiferae as new cell factories for producing silver nanoparticles,” J. Microbiol. Biotechnol., vol. 28, no. 10, pp. 1654–1663, 2018, doi: 10.4014/jmb.1806.06023. 

[24] G. A. Costa et al., “Evaluation antibacterial and antibiofilm activity of the antimicrobial peptide P34 against Staphylococcus aureus and Enterococcus faecalis,” An. Acad. Bras. Cienc., vol. 90, no. 1, pp. 73–84, 2018, doi: 10.1590/0001-3765201820160131. 

[25] R. Seng et al., “Biofilm formation of methicillin-resistant coagulase negative staphylococci (MR-CoNS) isolated from community and hospital environments,” PLoS One, vol. 12, no. 8, pp. 1–13, 2017, doi: 10.1371/journal.pone.0184172. 

[26] C. S. Aher, "The isolation pattern, species distribution and antibiotic susceptibility profile of coagulase negative Staphylococci : emerging opportunistic pathogens * Correspondence Info :," nt J Biomed Adv Res, vol. 3809, pp. 1–3, 2014, doi: 10.7439/ijbar. 

[27] A. Debnath, D. Ghosh, and R. Ghosh, “Detection of Antibiotic Susceptibility Pattern and Methicillin Resistance among the Clinical Isolates of Coagulase Negative Staphylococci ( CONS ) in a Rural Tertiary Care Hospital,” Int. J. Heal. Sci. Res., vol. 10, no. June, pp. 338–345, 2020. 

[28] T. Kitti, R. Seng, R. Thummeepak, and S. Sitthisak, “Biofilm Formation of Methicillin-resistant Coagulase-Negative Staphylococci Isolated from Clinical Samples in Northern Thailand,” J. Glob. Infect. Dis., vol. 11, no. 3, p. 112, 2019, doi: 10.4103/jgid.jgid. 

[29] S. Teeraputon et al., “Prevalence of methicillin resistance and macrolide – lincosamide – streptogramin B resistance in Staphylococcus haemolyticus among clinical strains at a tertiary-care hospital in Thailand,” New Microbes New Infect., vol. 19, pp. 28–33, 2017, doi: 10.1016/j.nmni.2017.05.007. 

[30] R. M. A. Halim, N. N. Kassem, and B. S. Mahmoud, “Detection of biofilm producing staphylococci among different clinical isolates and its relation to methicillin susceptibility,” Open Access Maced. J. Med. Sci., vol. 6, no. 8, pp. 1335–1341, 2018, doi: 10.3889/oamjms.2018.246. 

[31] C. Secchi et al., “Identification and Detection of Methicillin Resistance in Non -Epidermidis Coagulase.Negative Staphylococci,” Brazilian J. Infect. Dis., vol. 12, pp. 316–320, 2008.

[32] A. Socohou et al., "Antibiotics Resistance and Biofilm Formation Capacity of Staphylococcus spp. Strains Isolated from Surfaces and Medicotechnical Materials," Int. J. Microbiol., vol. 2020, 2020. 

[33] R. D. Walker, Standards for antimicrobial susceptibility testing., vol. 60, no. 9. 1999. 

[34] F. Ã. Koksal, H. Yasar, and M. Samasti, "Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey," Microbiol. Res., vol. 164, no. 4, pp. 404–410, 2007, doi: 10.1016/j.micres.2007.03.004. 

[35] Z. K. Al-sultany and A. H. Al-charrakh, “Antibiotic resistance patterns of coagulase negative Staphylococcus (CoNS) strains isolated from blood stream infections in Babylon province, Iraq,” Ann. Trop. Med. Public Heal., vol. 23, no. 16, pp. 231–633, 2020, doi: 10.36295/ASRO.2020.231633. 

[36] S. Natoli et al., “Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options,” BMC Infect. Dis., vol. 9, no. 1, pp. 1– 8, 2009. 

[37] W. Chajkecka-Wierzchowska, A. Zadernowska, B. Nalepa, M. Sierpińska, and Ł. Łaniewska.Trokenheim, “Coagulase-negative staphylococci (CoNS) isolated from ready-to-eat food of animal origin--phenotypic and genotypic antibiotic resistance,” Food Microbiol., vol. 46, pp. 222–226, 2015, doi: 10.1016/j.fm.2014.08.001. 

[38] S. Dzhoraeva, N. Sobol, and H. Ivantsova, “Phenotypical characteristics of the biological properties of staphylococci withdrawn from patients with allergic dermatitis,” EUREKA Heal. Sci., no. 1, pp. 15–21, JZS-A Volume 24, Issue 1, June 2022 26 2020, doi: 10.21303/2504-5679.2020.001125. 

[39] M. S. Okee et al., "Original Article Prevalence of virulence determinants in Staphylococcus epidermidis from ICU patients in Kampala, Uganda," J. Infect. Dev. Ctries., vol. 6, pp. 242--250, 2012. 

[40] M. Nasaj, Z. Saeidi, B. Asghari, G. Roshanaei, and M. R. Arabestani, “Identification of hemolysin encoding genes and their association with antimicrobial resistance pattern among clinical isolates of coagulase-negative Staphylococci,” BMC Res. Notes, vol. 13, no. 1, pp. 4–9, 2020, doi: 10.1186/s13104- 020-4938-0. 

[41] D. Ariyanti, S. Isrina, O. Salasia, and S. Tato, “Characterization of Haemolysin of Staphylococcus aureus Isolated from Food of Animal Origin,” Indones. J. Biotechnol., vol. 16, no. I, pp. 32–37, 2011. 

[42] R. A. Nasr, H. M. AbuShady, and H. S. Hussein, “Biofilm formation and presence of icaAD gene in clinical isolates of staphylococci,” Egypt. J. Med. Hum. Genet., vol. 13, no. 3, pp. 269–274, 2012, doi: 10.1016/j.ejmhg.2012.04.007. 

[43] R. F. Rampelotto et al., “Assessment of different methods for the detection of biofilm production in coagulase-negative staphylococci isolated from blood cultures of newborns,” Rev. Soc. Bras. Med. Trop., vol. 51, no. 6, pp. 761–767, 2018, doi: 10.1590/0037-8682-0171-2018. 

[44] B. Serray et al., "Genes encoding adhesion factors and biofilm formation in methicillin-resistant Staphylococcus aureus in Morocco," J. Infect. Dev. Ctries., vol. 10, no. 08, 2016, doi: 10.3855/jidc.8361. 

[45] C. R. Arciola and L. Baldassarri, “Presence of icaA and icaD Genes and Slime Production in a Collection of Staphylococcal Strains from Catheter-Associated Infections,” J. Clin. Microbiol., vol. 39, no. 6, pp. 2151–2156, 2001, doi: 10.1128/JCM.39.6.2151. 

[46] K. M. Conlon, H. Humphreys, and J. P. O. Gara, “icaR Encodes a Transcriptional Repressor Involved in Environmental Regulation of ica Operon Expression and Biofilm Formation in Staphylococcus epidermidis,” J. Bacteriol., vol. 184, no. 16, pp. 4400–4408, 2002, doi: 10.1128/JB.184.16.4400. 

[47] S. Dobinsky et al., “Glucose-Related Dissociation between icaADBC Transcription and Biofilm Expression by Staphylococcus epidermidis : Evidence for an Additional Factor Required for Polysaccharide Intercellular Adhesin Synthesis,” J. Bacteriol., vol. 185, no. 9, pp. 2879–2886, 2003, doi: 10.1128/JB.185.9.2879. 

[48] M. Yousefi, M. R. Pourmand, F. Fallah, A. Hashemi, R. Mashhadi, and A. Nazari-Alam, “Characterization of Staphylococcus aureus biofilm formation in urinary tract infection,” Iran. J. Public Health, vol. 45, no. 4, pp. 485–493, 2016. 

[49] N. Giormezis et al., “Coagulase-negative staphylococcal bloodstream and prosthetic-device-associated infections: the role of biofilm formation and distribution of adhesin and toxin genes,” J. Med. Microbiol., no. 2014, pp. 1500–1508, 2017, doi: 10.1099/jmm.0.075259-0. 

[50] M. Otto, “Staphylococcal Biofilms,” in Bacterial Biofilms, T. Romeo, Ed. Springer, Berlin, Heidelberg, 2008, pp. 207–228